Literature DB >> 30191491

Computational Identification of Cross-Talking ceRNAs.

Yongsheng Li1, Caiqin Huo2, Xiaoyu Lin2, Juan Xu2.   

Abstract

Competing endogenous RNAs (ceRNAs) are kinds of RNAs that regulate each other at post-transcription level through competing for miRNA regulators. CeRNA-ceRNA networks provide another type of function for protein-coding mRNAs, which link non-coding RNAs such as miRNA, long non-coding RNA, pseudogenes and circular RNAs. In this chapter, we will introduce the definition of ceRNAs, mainly provide the computational method to predict ceRNA interactions in general condition and complex diseases. In addition, we also illustrated several computational methods that are commonly used to identify the perturbed ceRNA networks in human diseases compared to normal conditions. Finally, we also summarized the principles of methods that integrated ceRNA theory to identify human disease biomarkers. Understanding of RNA-RNA crosstalk will provide significant insights into gene regulatory network that has been implicated in human development and/or diseases.

Entities:  

Keywords:  Competing endogenous RNAs; Crosstalk; Pan-cancer; miRNA targets

Mesh:

Substances:

Year:  2018        PMID: 30191491     DOI: 10.1007/978-981-13-0719-5_10

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  17 in total

1.  Mechanosensitive pathways are regulated by mechanosensitive miRNA clusters in endothelial cells.

Authors:  Sean Herault; Jarka Naser; Daniele Carassiti; K Yean Chooi; Rosa Nikolopoulou; Marti Llopart Font; Miten Patel; Ryan Pedrigi; Rob Krams
Journal:  Biophys Rev       Date:  2021-10-23

2.  KCNQ1OT1/miR-18b/HMGA2 axis regulates high glucose-induced proliferation, oxidative stress, and extracellular matrix accumulation in mesangial cells.

Authors:  Jia Li; Mingming Li; Ling Bai
Journal:  Mol Cell Biochem       Date:  2020-09-29       Impact factor: 3.396

Review 3.  Noncoding RNA crosstalk in brain health and diseases.

Authors:  Suresh L Mehta; Anil K Chokkalla; Raghu Vemuganti
Journal:  Neurochem Int       Date:  2021-07-16       Impact factor: 4.297

Review 4.  Pseudogenes in Cardiovascular Disease.

Authors:  Yanyan Qi; Xi Wang; Wenbo Li; Dongchang Chen; Hua Meng; Songtao An
Journal:  Front Mol Biosci       Date:  2021-02-10

5.  LncRNA DIO3OS regulated by TGF-β1 and resveratrol enhances epithelial mesenchymal transition of benign prostatic hyperplasia epithelial cells and proliferation of prostate stromal cells.

Authors:  Yanbo Chen; Hui Xu; Chong Liu; Meng Gu; Ming Zhan; Qi Chen; Zhong Wang
Journal:  Transl Androl Urol       Date:  2021-02

Review 6.  Functional Interactions Between lncRNAs/circRNAs and miRNAs: Insights Into Rheumatoid Arthritis.

Authors:  Juan-Juan Han; Xue-Qiang Wang; Xin-An Zhang
Journal:  Front Immunol       Date:  2022-02-07       Impact factor: 7.561

7.  Expression profile of circular RNAs in the peripheral blood of neonates with hypoxic‑ischemic encephalopathy.

Authors:  Xiaohua Dong; Sisi Zhuang; Yun Huang; Xiaojing Yang; Yanrong Fu; Lingling Yu; Yingmin Zhao
Journal:  Mol Med Rep       Date:  2020-04-23       Impact factor: 2.952

8.  Identification of candidate lncRNAs and circRNAs regulating WNT3/β-catenin signaling in essential hypertension.

Authors:  Liang Yin; Jie Yao; Guangxue Deng; Xuemei Wang; Weijuan Cai; Jie Shen
Journal:  Aging (Albany NY)       Date:  2020-05-11       Impact factor: 5.682

9.  Systematic Analysis of Competing Endogenous RNA Networks in Diffuse Large B-Cell Lymphoma and Hodgkin's Lymphoma.

Authors:  Juanjuan Kang; Pengcheng Yao; Qiang Tang; Ying Wang; Yuwei Zhou; Jian Huang
Journal:  Front Genet       Date:  2020-09-30       Impact factor: 4.599

10.  LncRNA CASC19 accelerates chondrocytes apoptosis and proinflammatory cytokine production to exacerbate osteoarthritis development through regulating the miR-152-3p/DDX6 axis.

Authors:  Chang Zhou; Tianda He; Liji Chen
Journal:  J Orthop Surg Res       Date:  2021-06-22       Impact factor: 2.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.